Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Deep Brain StimulationParkinson Disease
Interventions
OTHER

Adaptive DBS

The Medtronic Percept device will be activated with the aDBS functionality. Participant will receive adaptive DBS.

OTHER

Continue DBS

The Medtronic Percept device will be equipped with aDBS functionality (to maintain the blinding of the allocation), but this functionality will remain inactive. Participant will receive continue DBS.

Trial Locations (3)

Unknown

Amsterdam UMC, Amsterdam

Maastricht UMC+, Maastricht

HagaZiekenhuis, The Hague

All Listed Sponsors
collaborator

HagaZiekenhuis

OTHER

collaborator

Maastricht University Medical Center

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT06909045 - Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease | Biotech Hunter | Biotech Hunter